Select region
Submit

Subscribe to our news feed

Subscribe

A question?

22/04/2024
Resolutions at Getinge’s Annual General Meeting 22 April 2024

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on 22 April 2024 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

22/04/2024
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value

“Net sales increased by 5.2% in the first quarter, of which organic net sales was unchanged despite challenging comparative figures,” says Mattias Perjos, President & CEO at Getinge. “We have a strong free cash flow and a solid financial position that enables investments in profitable growth.”

18/04/2024
NAVA – a gamechanger for neonatal care in Slovakia

When using Getinge’s patented Neurally Adjusted Ventilatory Assist (NAVA) with diaphragm monitoring (Edi) for the first time in 2021, it soon became clear to the neonatal team in the F.D. Roosevelt University Hospital in Banska Bystrica, Slovakia, that the solution would become a gamechanger for their treatment of premature babies.

08/04/2024
Getinge invites fund managers, analysts, and media to Q1 Report 2024 conference call

Getinge will issue its Q1 Report 2024 on April 22, 2024, at 12:00 p.m. CEST, followed by a conference call at 13:00-14.00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

28/03/2024
Getinge extends the bioreactor portfolio with larger single-use systems

Getinge is extending its bioreactor offering by introducing the Single-Use Production Reactor (SUPR) system, which initially is available in 50-liter and 250-liter sizes. Based on the same proven platform as Getinge’s smaller bioreactors, the SUPR system helps operators to bring life-saving medicines faster to market, aiming to improve people’s quality of life.

28/03/2024
Getinge donates life-saving medical equipment to Ukraine

In a time where medical assistance is critical, Getinge donates extensive medical equipment to Ukraine. The donation, made in collaboration with the Ministry of Health Ukraine, includes a significant number of anesthesia machines and ventilators, aimed at directly improving healthcare and increasing the country's resilience against the challenges of war.

Press Contacts

Jeanette Hedén Carlsson

EVP Brand & Communication
Phone: +46 10 335 1003

Anna Appelqvist

Vice President Corporate Communications
Phone: +46 10 335 5906

Newsroom2

Prefer to contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Newsroom

Don't miss anything

Click on the icons and follow us!